article thumbnail

Employment Considerations in Portfolio Company Acquisitions

JD Supra: Mergers

A private equity (PE) firm’s primary objective is to generate returns on its investments. When a PE firm acquires a portfolio company (PortCo), one way the PE firm increases its returns is by making employment-related changes—sometimes significant ones—at the PortCo level.

Portfolio 177
article thumbnail

Eyes on the exit: Selling PE portfolio companies in complex markets

JD Supra: Mergers

Sluggish M&A and IPO markets have put the brakes on private equity exit activity across Europe, but as pressure builds to clear the backlog of unsold portfolio companies, firms are taking innovative approaches to selling businesses - Europes private equity firms have a large backlog of unsold portfolio companies sitting on their books, and the (..)

Portfolio 171
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Trends in Equity Repurchasing in PE: Rollover vs. Incentive Equity

JD Supra: Mergers

Private equity (PE) sponsors often provide incentives to founders, equity holders, employees, directors, and officers of portfolio companies in the form of rollover equity or incentive equity to align their interests with those of the sponsors. By: Goodwin

Equities 165
article thumbnail

The Role of Private Equity Consulting in Portfolio Company Growth Strategies

OfficeHours

Private equity consulting firms play a crucial role in the success of portfolio companies by providing specialized expertise and strategic guidance. Private equity consulting firms go beyond traditional advisory services by providing value-added services to their clients.

article thumbnail

Trending Enforcement Targeting Private Equity Healthcare Portfolios Provides Important Compliance Reminder

JD Supra: Mergers

Over the last decade, private equity firms have acquired healthcare companies, hospitals, and clinics at an increasing rate. In fact, in those ten years, private equity firms have spent roughly $1 trillion on an estimated 8,000 healthcare deals. This trend is only expected to increase through 2024.

article thumbnail

Federal Court Dismisses Antitrust Claims Against Private Equity Firm

JD Supra: Mergers

Private equity firms can breathe a sigh of relief after a federal judge dismissed claims that threatened to establish a precedent for holding private equity firms liable for certain actions by their portfolio companies. By: Troutman Pepper

article thumbnail

Delaware Court Of Chancery Finds That Controller Sale Of Company Did Not Harm Minority Interests

JD Supra: Mergers

On January 7, 2025, Vice Chancellor Sam Glasscock III of the Delaware Court of Chancery issued a post-trial decision in favor of defendant, a private equity fund (the Fund), finding that the Funds sale of a portfolio company (the Company) was protected by the business judgment rule and did not harm the interests of minority stockholders.

Sale 165